Figure 3. PCR-based DGGE fingerprints of the methanogens-denaturants gradient from 40 to 60%- (a) and archaea- denaturants gradient from 50 to 60%- (b) present in the CDT treating POME using methanogenc and archaeal primers.
Lane 1 (a): Methanogens present in the anaerobic bioreactor; Lane 1 (b) Archaea present in the anaerobic bioreactor; Lane 2 and 3: Methanosaeta concilii (SamaliEB and Samali15).